Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

Polymorphisms of FGFR1 in HBV-related Hepatocellular Carcinoma

Genetic Polymorphisms of Xrcc1 Gene and Susceptibility to Hepatocellular Carcinoma in Chinese Population

Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle

Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.

Association Between Fibroblast Growth Factor Receptor 4 Polymorphisms and Risk of Hepatocellular Carcinoma.

The Association Between Polymorphisms Of Class Ii Cytokine Receptor Genes And Risk Of Hbv-Related Hepatocellular Carcinoma

Association of a functional intronic polymorphism rs 735396 in HNF 1 A gene with the susceptibility to hepatocellular carcinoma in Han Chinese population

Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.

[Correlation Between Interleukin-28B Genetic Polymorphisms and Primary Hepatocellular Carcinoma].

Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population

Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival

Association Between Epidermal Growth Factor 61A/G Polymorphism and Hepatocellular Carcinoma Susceptibility in Chinese Patients

FABP1 Polymorphisms Contribute to Hepatocellular Carcinoma Susceptibility in Chinese Population with Liver Cirrhosis: A Case-Control Study

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and prognosis in Chinese population

Genetic Variants in Glucose-6-phosphate Isomerase Gene As Prognosis Predictors in Hepatocellular Carcinoma.

Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer

No association of EGF 5'UTR variant A61G and hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Potentially Functional Genetic Variants in the NRF2 Signaling Pathway Genes Are Associated with HBV-related Hepatocellular Carcinoma Survival.

An Intronic Polymorphism in the Corticotropin-Releasing Hormone Receptor 2 Gene Increases Susceptibility to Hbv-Related Hepatocellular Carcinoma in Chinese Population